Fig. 4.
![Fig. 4. Five-year overall survival. / Actuarial 5-year overall survival of patients grafted with low ([A] ≤ 2.4 × 108/kg; n = 247, 45%), intermediate ([B] > 2.4 × 108/kg and ≤ 5 × 108/kg; n = 452, 51%), and high cell dose ([C] > 5 × 108/kg; n = 206, 56%). Pvalues in the log-rank test are as follows: A versus B,P < .06; A versus C, P < .007; and B versus C, P = .2.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/100/12/10.1182_blood-2002-01-0339/5/h82323454004.jpeg?Expires=1722406147&Signature=PFlGaThSBemE2MHBxmMjmxKNXEHQzcZM5GxQEMfU~c4vznWc0s6W2ca9r7bTkvLiAnZ2cAyXLyYHNGTVtL60~VcfSWLR1wW6XRUWvwxEoMbvo5rft0LpKTIcyNzv~yzx6tEu1q50aCK26QGP6wspEM-t2yHzALREjEc6azQB6UOLG2GVDjcdvK8Wougc-QkT-2Iws7EPvsCD39lWmkimj04Sxc9JP-j6bWiX7rmekKKFsWMapmuvxS2gh8N9melkEQ~xpwkJFbMrr~uodSxuXJWu01jMXEd3qdDrx514mC~MCg4VJjm3ZdihsmOp~9-R4XBYiVrb3y69YAQrh-sloA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Five-year overall survival.
Actuarial 5-year overall survival of patients grafted with low ([A] ≤ 2.4 × 108/kg; n = 247, 45%), intermediate ([B] > 2.4 × 108/kg and ≤ 5 × 108/kg; n = 452, 51%), and high cell dose ([C] > 5 × 108/kg; n = 206, 56%). Pvalues in the log-rank test are as follows: A versus B,P < .06; A versus C, P < .007; and B versus C, P = .2.
